Vaaji
Vaaji is a pharmaceutical company focused on revolutionizing transdermal medication patches through the integration of AI and IoT technology. Their proprietary system monitors patch usage in real-time, detects and intervenes in application errors, and provides intelligent reporting to improve patient safety and outcomes. The company's initial focus is on Alzheimer's patient care, developing a smart rivastigmine patch to reduce application errors and promote aging at home. Vaaji's technology is designed to be scalable and integrable with existing transdermal therapies, aiming to enhance the safety of pain management treatments and serve diverse patient populations. The company has received a pilot award from the Penn AI and Technology Collaboratory, funded by the National Institute of Aging, to improve the safety of transdermal therapeutics for Alzheimer's patients.
Vaaji
Vaaji is a pharmaceutical company focused on revolutionizing transdermal medication patches through the integration of AI and IoT technology. Their proprietary system monitors patch usage in real-time, detects and intervenes in application errors, and provides intelligent reporting to improve patient safety and outcomes. The company's initial focus is on Alzheimer's patient care, developing a smart rivastigmine patch to reduce application errors and promote aging at home. Vaaji's technology is designed to be scalable and integrable with existing transdermal therapies, aiming to enhance the safety of pain management treatments and serve diverse patient populations. The company has received a pilot award from the Penn AI and Technology Collaboratory, funded by the National Institute of Aging, to improve the safety of transdermal therapeutics for Alzheimer's patients.